Who makes transdermal DMPS?

transdermal DMPS is developed by Banner Health.

What development phase is transdermal DMPS in?

transdermal DMPS is in Phase 1.

Last reviewed 2026-04-20 · How we verify

transdermal DMPS

Banner Health · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	transdermal DMPS
Sponsor	Banner Health
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Transdermal Absorption of Dimercaptopropane-1-Sulfonate (DMPS) and Effect on Urinary Mercury Excretion (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

transdermal DMPS CI brief — competitive landscape report
transdermal DMPS updates RSS · CI watch RSS
Banner Health portfolio CI